Comparison of NT Vs Body Weight Supported TT Along With CT on Lower Extremity in Chronic Stroke Patients

Sponsor
Superior University (Other)
Overall Status
Completed
CT.gov ID
NCT05376982
Collaborator
(none)
42
1
2
4
10.4

Study Details

Study Description

Brief Summary

To determine the effect of Neurodevelopment Treatment vs Body Weight Supported Treadmill Training along with conventional therapy on lower extremity among chronic stroke patients.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Neurodevelopmental Treatment
  • Diagnostic Test: Body weight supported treadmill training along with conventional therapy
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
42 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Health Services Research
Official Title:
Comparison of Neurodevelopmental Treatment Vs Body Weight Supported Treadmill Training Along With Conventional Therapy on Lower Extremity Among Chronic Stroke Patients
Actual Study Start Date :
Mar 31, 2022
Actual Primary Completion Date :
Jul 13, 2022
Actual Study Completion Date :
Aug 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Neurodevelopmental Treatment

Using Neurodevelopmental Treatment Method

Diagnostic Test: Neurodevelopmental Treatment
Using Neurodevelopmental Treatment Method

Experimental: Body weight supported treadmill training along with conventional therapy

Using Body weight supported treadmill training along with conventional therapy Method

Diagnostic Test: Body weight supported treadmill training along with conventional therapy
Using Body weight supported treadmill training along with conventional therapy Method

Outcome Measures

Primary Outcome Measures

  1. For lower extremity among chronic stroke patients [6 Months]

    comparison of neurodevelopmental treatment vs body weight supported treadmill training along with conventional therapy on lower extremity among chronic stroke patients

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Application of M-Cog test for checking patients cognition.

  • Chronic ischemic stroke patients.

  • Both Male and Female Patients.

  • Patients of 35 or above years of age.

Exclusion Criteria:
  • Patients with history of recurrent stroke.

  • Patients with lower limb fractures or dislocations.

  • Patients with Peripheral vascular disease

  • Patients with skin discoloration or skin ulcers.

Contacts and Locations

Locations

Site City State Country Postal Code
1 • General Hospital. • Chaudhary Muhammad Akram Teaching and Research Hospital, University of Lahore Teaching Hospital, Shadman Medical Center, Services Hospital, Bahria International Hospital Lahore Pakistan

Sponsors and Collaborators

  • Superior University

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Muhammad Naveed Babur, Principal Investigator, Superior University
ClinicalTrials.gov Identifier:
NCT05376982
Other Study ID Numbers:
  • DPT/Batch-Fall17/506
First Posted:
May 17, 2022
Last Update Posted:
Aug 4, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 4, 2022